Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell of lymphatic vessel | 6 studies | 25% ± 11% | |
B cell | 3 studies | 23% ± 2% | |
endothelial cell | 3 studies | 20% ± 4% |
Insufficient scRNA-seq data for expression of GRAP at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 80.30 | 89 / 89 | 55% | 1.58 | 492 / 901 |
thymus | 100% | 96.43 | 651 / 653 | 43% | 1.17 | 261 / 605 |
breast | 100% | 109.05 | 459 / 459 | 35% | 0.57 | 395 / 1118 |
lung | 100% | 120.99 | 578 / 578 | 31% | 0.53 | 356 / 1155 |
intestine | 87% | 79.16 | 845 / 966 | 31% | 0.62 | 166 / 527 |
adrenal gland | 98% | 51.49 | 252 / 258 | 16% | 0.37 | 36 / 230 |
uterus | 98% | 60.66 | 167 / 170 | 12% | 0.22 | 56 / 459 |
brain | 70% | 20.85 | 1843 / 2642 | 40% | 0.71 | 279 / 705 |
bladder | 90% | 40.52 | 19 / 21 | 17% | 0.34 | 85 / 504 |
stomach | 69% | 19.41 | 246 / 359 | 33% | 0.64 | 95 / 286 |
spleen | 100% | 528.56 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 107.27 | 1201 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 212.52 | 904 / 929 | 0% | 0 | 0 / 0 |
prostate | 93% | 44.48 | 228 / 245 | 4% | 0.05 | 18 / 502 |
lymph node | 0% | 0 | 0 / 0 | 93% | 9.23 | 27 / 29 |
esophagus | 82% | 26.78 | 1187 / 1445 | 8% | 0.14 | 14 / 183 |
skin | 59% | 24.53 | 1076 / 1809 | 29% | 0.67 | 136 / 472 |
liver | 72% | 31.22 | 162 / 226 | 10% | 0.18 | 39 / 406 |
heart | 80% | 24.74 | 689 / 861 | 0% | 0 | 0 / 0 |
ovary | 71% | 25.98 | 127 / 180 | 4% | 0.06 | 17 / 430 |
pancreas | 18% | 4.09 | 60 / 328 | 40% | 0.81 | 71 / 178 |
blood vessel | 48% | 18.00 | 643 / 1335 | 0% | 0 | 0 / 0 |
muscle | 35% | 8.20 | 283 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 33% | 0.54 | 15 / 45 |
eye | 0% | 0 | 0 / 0 | 3% | 0.03 | 2 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0007605 | Biological process | sensory perception of sound |
GO_0007265 | Biological process | Ras protein signal transduction |
GO_0043408 | Biological process | regulation of MAPK cascade |
GO_0007267 | Biological process | cell-cell signaling |
GO_0008180 | Cellular component | COP9 signalosome |
GO_0098793 | Cellular component | presynapse |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005154 | Molecular function | epidermal growth factor receptor binding |
GO_0005515 | Molecular function | protein binding |
GO_0001784 | Molecular function | phosphotyrosine residue binding |
Gene name | GRAP |
Protein name | GRB2 related adaptor protein GRB2-related adapter protein |
Synonyms | |
Description | FUNCTION: Couples signals from receptor and cytoplasmic tyrosine kinases to the Ras signaling pathway. Plays a role in the inner ear and in hearing . . |
Accessions | ENST00000284154.10 A8MW78 ENST00000395635.5 J3QRP9 ENST00000583020.1 Q13588 I3L2P9 ENST00000573099.5 |